Literature DB >> 3801069

Modulation of spontaneous immunoglobulin production by natural killer cells in rheumatoid arthritis.

Z Tovar, R M Pope, N Talal.   

Abstract

Synovial fluid (SF) mononuclear cells obtained from patients with rheumatoid arthritis (RA) spontaneously produce large amounts of immunoglobulin. In the rheumatoid joint, natural killer (NK) cell activity is reduced in comparison with that in the peripheral blood (PB). We examined the ability of SF NK cells to modulate the spontaneous production of Ig in RA SF, and we contrasted this with the activity in PB from RA patients and from normal subjects. We found that the spontaneous production of IgG was greater in RA SF than in RA or normal PB. The baseline NK activity was significantly lower in RA SF than in RA or normal PB (P less than 0.005). Incubation with anti-Leu-11b and complement reduced NK activity in PB, but not in SF, and it significantly (P less than or equal to 0.021) increased IgG production in both RA SF and RA PB. Lysis of NK cells in this manner also resulted in a significant increase (P less than 0.02) in IgM production in RA SF. These results suggest that NK cells with a Leu-11b phenotype down-regulate the ongoing synthesis of IgG and IgM in the rheumatoid joint.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3801069     DOI: 10.1002/art.1780291203

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  3 in total

Review 1.  Natural killer cells and autoimmunity.

Authors:  E Grunebaum; E Malatzky-Goshen; Y Shoenfeld
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  NK cells blur the frontier between innate and acquired immunity.

Authors:  Giuseppe Terrazzano; Ennio Carbone
Journal:  Front Immunol       Date:  2013-01-02       Impact factor: 7.561

Review 3.  Rheumatoid arthritis and systemic lupus erythematosus: Pathophysiological mechanisms related to innate immune system.

Authors:  Maria Angélica Pabón-Porras; Sebastian Molina-Ríos; Jorge Bruce Flórez-Suárez; Paola Ximena Coral-Alvarado; Paul Méndez-Patarroyo; Gerardo Quintana-López
Journal:  SAGE Open Med       Date:  2019-09-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.